{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T14:13:13Z","timestamp":1772201593791,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The pathogenesis of diabetic kidney disease (DKD) is complex and involves both glomerular and tubular dysfunction. A global assessment of kidney function is necessary to stage DKD, a progressive kidney disease that is likely to begin in childhood. The present study evaluated whether kidney injury biomarkers identified as early DKD biomarkers in adults have any prognostic value in the very early stages of childhood diabetes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We measured urine free Retinol-binding protein 4 (UfRBP4), albumin (UAlb), Kidney injury molecule-1 (KIM-1) and the microRNAs miR-155, miR-126 and miR-29b in two cohorts of paediatric T1DM patients without evidence of DKD, but with diabetes of short-duration,\u2009\u2264\u20092.5\u00a0years (SD, n\u2009=\u200925) or of long-duration,\u2009\u2265\u200910\u00a0years (LD, n\u2009=\u200929); non-diabetic siblings (H, n\u2009=\u200926) were recruited as controls. A p value\u2009&lt;\u20090.05 was considered significant for all results.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>UfRBP4 and UAlb were not significantly different across the three groups. No differences were found in KIM-1 excretion between any of the three groups. UfRBP4 was correlated with UAlb in all three groups (r 0.49; p\u2009&lt;\u20090.001), whereas KIM-1 showed no correlation with albumin excretion. Among microRNAs, miR-29b was higher in all diabetic children compared with the H control group (p\u2009=\u20090.03), whereas miR-155 and miR-126 were not significantly different. No differences were found between the SD and LD groups for all three microRNAs. No associations were identified between these biomarkers with sex, age, BMI, eGFR, T1DM duration or glycaemic control.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>UfRBP4, KIM-1, miR-155, and miR-126 were unaffected by the presence and duration of diabetes, whereas miR-29b showed a modest elevation in diabetics, regardless of duration. These data support the specificity of a panel of urine biomarkers as DKD biomarkers, rather than any relationship to diabetes per se or its duration, and not as early DKD biomarkers in a paediatric setting.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13098-022-00839-4","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T11:04:04Z","timestamp":1652353444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploration of a panel of urine biomarkers of kidney disease in two paediatric cohorts with Type 1 diabetes mellitus of differing duration"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9221-5698","authenticated-orcid":false,"given":"Letizia","family":"Zeni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony G. W.","family":"Norden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Prandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Canepa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Burling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Felappi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Cancarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro Manuel","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Unwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"key":"839_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-physiol-020911-153333","volume":"74","author":"V Vallon","year":"2012","unstructured":"Vallon V, Thomson SC. Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Annu Rev Physiol. 2012;74:351\u201375.","journal-title":"Annu Rev Physiol"},{"key":"839_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.semnephrol.2007.01.012","volume":"27","author":"P Fioretto","year":"2007","unstructured":"Fioretto P, Mauer M. Histopathology of diabetic nephropathy. Semin Nephrol. 2007;27:195\u2013207.","journal-title":"Semin Nephrol"},{"key":"839_CR3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jdiacomp.2016.10.030","volume":"31","author":"F Viazzi","year":"2017","unstructured":"Viazzi F, Piscitelli P, Giorda C, Ceriello A, Genovese S, Russo GT, et al. Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes. J Diabetes Complicat. 2017;31:419\u201326.","journal-title":"J Diabetes Complicat"},{"key":"839_CR4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s40620-017-0423-9","volume":"30","author":"L Zeni","year":"2017","unstructured":"Zeni L, Norden AG, Cancarini G, Unwin RJ. A more tubulocentric view of diabetic kidney disease. J Nephrol. 2017;30:701\u201317.","journal-title":"J Nephrol"},{"key":"839_CR5","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.03.026","author":"JH Ix","year":"2021","unstructured":"Ix JH, Shlipak MG. The promise of tubule biomarkers in kidney disease: a review. Am J Kidney Dis. 2021. https:\/\/doi.org\/10.1053\/j.ajkd.2021.03.026.","journal-title":"Am J Kidney Dis"},{"key":"839_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S2213-8587(19)30086-5","volume":"7","author":"C Pollock","year":"2019","unstructured":"Pollock C, Stef\u00e1nsson B, Reyner D, Rossing P, Sj\u00f6str\u00f6m CD, Wheeler DC, et al. Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019;7:429\u201341.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"839_CR7","doi-asserted-by":"publisher","first-page":"m4573","DOI":"10.1136\/bmj.m4573","volume":"372","author":"SC Palmer","year":"2021","unstructured":"Palmer SC, Tendal B, Mustafa RA, Vandvik PO, Li S, Hao Q, et al. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2021;372:m4573.","journal-title":"BMJ"},{"key":"839_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/B978-0-12-800094-6.00003-0","volume":"63","author":"AG Norden","year":"2014","unstructured":"Norden AG, Lapsley M, Unwin RJ. Urine retinol-binding protein 4: a functional biomarker of the proximal renal tubule. Adv Clin Chem. 2014;63:85\u2013122.","journal-title":"Adv Clin Chem"},{"key":"839_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cca.2011.11.007","volume":"413","author":"KA Burling","year":"2012","unstructured":"Burling KA, Cutillas PR, Church D, Lapsley M, Norden AG. Analysis of molecular forms of urine Retinol-Binding Protein in Fanconi Syndrome and design of an accurate immunoassay. Clin Chim Acta. 2012;413:483\u20139.","journal-title":"Clin Chim Acta"},{"key":"839_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00592-012-0407-0","volume":"49","author":"A Soggiu","year":"2012","unstructured":"Soggiu A, Piras C, Bonizzi L, Hussein HA, Pisanu S, Roncada P. A discovery-phase urine proteomics investigation in type 1 diabetes. Acta Diabetol. 2012;49:453\u201364. https:\/\/doi.org\/10.1007\/s00592-012-0407-0.","journal-title":"Acta Diabetol"},{"key":"839_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s001250051603","volume":"44","author":"CJ Schultz","year":"2001","unstructured":"Schultz CJ, Dalton RN, Neil HAW, Konopelska-Bahu T, Dunger DB, Group ORPS. Markers of renal tubular dysfunction measured annually do not predict risk of microalbuminuria in the first few years after diagnosis of Type I diabetes. Diabetologia. 2001;44:224\u20139.","journal-title":"Diabetologia"},{"key":"839_CR12","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.cmet.2021.04.004","volume":"33","author":"Y Mori","year":"2021","unstructured":"Mori Y, Ajay AK, Chang J-H, Mou S, Zhao H, Kishi S, et al. KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease. Cell Metab. 2021;33:1042\u201361.","journal-title":"Cell Metab"},{"key":"839_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/ki.2010.404","volume":"79","author":"VS Vaidya","year":"2011","unstructured":"Vaidya VS, Niewczas MA, Ficociello LH, Johnson AC, Collings FB, Warram JH, et al. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-\u03b2-D-glucosaminidase. Kidney Int. 2011;79:464\u201370.","journal-title":"Kidney Int"},{"key":"839_CR14","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1097\/01.tp.0000295982.78039.ef","volume":"84","author":"MM Van Timmeren","year":"2007","unstructured":"Van Timmeren MM, Vaidya VS, van Ree RM, Oterdoom LH, de Vries AP, Gans RO, et al. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation. 2007;84:1625.","journal-title":"Transplantation"},{"key":"839_CR15","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.ajpath.2018.06.006","volume":"188","author":"C Beltrami","year":"2018","unstructured":"Beltrami C, Simpson K, Jesky M, Wonnacott A, Carrington C, Holmans P, et al. Association of elevated urinary miR-126, miR-155, and miR-29b with diabetic kidney disease. Am J Pathol. 2018;188:1982\u201392.","journal-title":"Am J Pathol"},{"key":"839_CR16","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.2337\/dc18-S012","volume":"41","author":"AD Association","year":"2018","unstructured":"Association AD. 12. Children and adolescents: standards of medical care in diabetes\u20142018. Diabetes Care. 2018;41:S126\u201336.","journal-title":"Diabetes Care"},{"key":"839_CR17","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","volume":"98","author":"IH de Boer","year":"2020","unstructured":"de Boer IH, Caramori ML, Chan JC, Heerspink HJ, Hurst C, Khunti K, et al. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2020;98:S1-115.","journal-title":"Kidney Int"},{"key":"839_CR18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/clinchem\/42.3.466","volume":"42","author":"J Mao","year":"1996","unstructured":"Mao J, Chen S, Na Z, Xhang Y, Huang Y, Li Y. Frozen storage of urine samples before ELISA measurement of retinol-binding protein. Clin Chem. 1996;42:466\u20137.","journal-title":"Clin Chem"},{"key":"839_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.ajkd.2015.04.040","volume":"67","author":"MP Schuh","year":"2016","unstructured":"Schuh MP, Nehus E, Ma Q, Haffner C, Bennett M, Krawczeski CD, et al. Long-term stability of urinary biomarkers of acute kidney injury in children. Am J Kidney Dis. 2016;67:56\u201361.","journal-title":"Am J Kidney Dis"},{"key":"839_CR20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1042\/BST20120090","volume":"40","author":"C Beltrami","year":"2012","unstructured":"Beltrami C, Clayton A, Phillips AO, Fraser DJ, Bowen T. Analysis of urinary microRNAs in chronic kidney disease. Biochem Soc Trans. 2012;40:875\u20139.","journal-title":"Biochem Soc Trans"},{"key":"839_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2217\/bmm.13.44","volume":"7","author":"C Mall","year":"2013","unstructured":"Mall C, Rocke DM, Durbin-Johnson B, Weiss RH. Stability of miRNA in human urine supports its biomarker potential. Biomark Med. 2013;7:623\u201331.","journal-title":"Biomark Med"},{"key":"839_CR22","unstructured":"Calculator: Body mass index (BMI) percentiles for girls (2 to 20 years) - UpToDate [Internet]. [cited 2020 Jun 1]. Available from: https:\/\/www.uptodate.com\/contents\/calculator-body-mass-index-bmi-percentiles-for-girls-2-to-20-years?search=children%20bmi&topicRef=5356&source=see_link."},{"key":"839_CR23","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/j.amepre.2011.06.044","volume":"41","author":"KR Laurson","year":"2011","unstructured":"Laurson KR, Eisenmann JC, Welk GJ. Body fat percentile curves for US children and adolescents. Am J Prev Med. 2011;41:S87-92.","journal-title":"Am J Prev Med"},{"key":"839_CR24","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1681\/ASN.2016060666","volume":"28","author":"L Tonneijck","year":"2017","unstructured":"Tonneijck L, Muskiet MH, Smits MM, Van Bommel EJ, Heerspink HJ, Van Raalte DH, et al. Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. J Am Soc Nephrol. 2017;28:1023\u201339.","journal-title":"J Am Soc Nephrol"},{"key":"839_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20:629\u201337.","journal-title":"J Am Soc Nephrol"},{"key":"839_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrneph.2012.19","volume":"8","author":"I Helal","year":"2012","unstructured":"Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol. 2012;8:293.","journal-title":"Nat Rev Nephrol"},{"key":"839_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/ncrna1020151","volume":"1","author":"C Beltrami","year":"2015","unstructured":"Beltrami C, Clayton A, Newbury LJ, Corish P, Jenkins RH, Phillips AO, et al. Stabilization of urinary microRNAs by association with exosomes and argonaute 2 protein. Non-coding RNA. 2015;1:151\u201366.","journal-title":"Non-coding RNA"},{"key":"839_CR28","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1177\/0962280215588241","volume":"25","author":"AL Whitehead","year":"2016","unstructured":"Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res. 2016;25:1057\u201373.","journal-title":"Stat Methods Med Res"},{"key":"839_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"A Levin","year":"2013","unstructured":"Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco AL, De Jong PE, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1\u2013150.","journal-title":"Kidney Int Suppl"},{"key":"839_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2019.04.017","author":"AG Norden","year":"2019","unstructured":"Norden AG, Burling KA, Zeni L, Unwin RJ. A new estimate of the glomerular sieving coefficient for retinol-binding protein4 suggests it is not freely-filtered. Kidney Int Rep. 2019. https:\/\/doi.org\/10.1016\/j.ekir.2019.04.017.","journal-title":"Kidney Int Rep"},{"key":"839_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1113\/JP280740","volume":"599","author":"A Edwards","year":"2021","unstructured":"Edwards A, Christensen EI, Unwin RJ, Norden AG. Predicting the protein composition of human urine in normal and pathological states: Quantitative description based on Dent1 disease (CLCN5 mutation). J Physiol. 2021;599:323\u201341.","journal-title":"J Physiol"},{"key":"839_CR32","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1681\/ASN.2021010094","volume":"32","author":"JH Greenberg","year":"2021","unstructured":"Greenberg JH, Abraham AG, Xu Y, Schelling JR, Feldman HI, Sabbisetti VS, et al. Urine biomarkers of kidney tubule health, injury, and inflammation are associated with progression of CKD in children. J Am Soc Nephrol. 2021;32:2664\u201377.","journal-title":"J Am Soc Nephrol"},{"key":"839_CR33","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.2337\/dc14-2330","volume":"38","author":"NM Panduru","year":"2015","unstructured":"Panduru NM, Sandholm N, Forsblom C, Saraheimo M, Dahlstr\u00f6m EH, Thorn LM, et al. Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes. Diabetes Care. 2015;38:1130\u20137.","journal-title":"Diabetes Care"},{"key":"839_CR34","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"Group AC","year":"2008","unstructured":"Group AC. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560\u201372.","journal-title":"N Engl J Med"},{"key":"839_CR35","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1007\/s00125-004-1431-6","volume":"47","author":"M Nordwall","year":"2004","unstructured":"Nordwall M, Bojestig M, Arnqvist HJ, Ludvigsson J. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of type 1 diabetes\u2014the link\u00f6ping diabetes complications study. Diabetologia. 2004;47:1266\u201372.","journal-title":"Diabetologia"},{"key":"839_CR36","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3389\/fgene.2019.00507","volume":"10","author":"HF Gu","year":"2019","unstructured":"Gu HF. Genetic and epigenetic studies in diabetic kidney disease. Front Genet. 2019;10:507.","journal-title":"Front Genet"},{"key":"839_CR37","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.2215\/CJN.02560607","volume":"2","author":"BI Freedman","year":"2007","unstructured":"Freedman BI, Bostrom M, Daeihagh P, Bowden DW. Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol. 2007;2:1306\u201316.","journal-title":"Clin J Am Soc Nephrol"},{"key":"839_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist E, Storm P, K\u00e4r\u00e4j\u00e4m\u00e4ki A, Martinell M, Dorkhan M, Carlsson A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6:361\u20139.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"839_CR39","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.2337\/dc14-1140","volume":"37","author":"JL Chiang","year":"2014","unstructured":"Chiang JL, Kirkman MS, Laffel LM, Peters AL. Type 1 diabetes through the life span: a position statement of the American diabetes association. Diabetes Care. 2014;37:2034\u201354.","journal-title":"Diabetes Care"},{"key":"839_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/gepi.10183","volume":"23","author":"S-W Guo","year":"2002","unstructured":"Guo S-W, Tuomilehto J. Preferential transmission of type 1 diabetes from parents to offspring: fact or artifact? Genet Epidemiol. 2002;23:323\u201334.","journal-title":"Genet Epidemiol"},{"key":"839_CR41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1530\/EJE-14-0247","volume":"171","author":"SE Park","year":"2014","unstructured":"Park SE, Lee NS, Park JW, Rhee E-J, Lee W-Y, Oh K-W, et al. Association of urinary RBP4 with insulin resistance, inflammation, and microalbuminuria. Eur J Endocrinol. 2014;171:443\u20139.","journal-title":"Eur J Endocrinol"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-022-00839-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-022-00839-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-022-00839-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T11:28:03Z","timestamp":1652354883000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-022-00839-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1186\/s13098-022-00839-4","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"assertion":[{"value":"19 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were in accordance with the ethical standards of the Institution and\/or National Research Committee and with the 1975 Helsinki Declaration and later amendments or comparable ethical standards. The study was approved by the Ethics Committee of Azienda Socio-Sanitaria Territoriale degli Spedali Civili di Brescia. All participants provided written informed consent. For minors, written informed consent was obtained from both parents and patients were also asked to give assent before the study. Patients aged 18\u00a0years or over provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declared no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}